Monitoring blood sugar swings to predict type 1 diabetes
Part of Hormones & metabolism clinical trials.
This study watches blood sugar changes over time in people who do not yet have diabetes but have test results that suggest risk for type 1 diabetes. The goal is to see whether “blood sugar variability” can predict when high or low blood sugar may happen, even before symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 5 and 39 years old
- You do not currently have diabetes based on standard diagnosis criteria
- Your blood tests show diabetes-related autoantibodies (IAA, GADA, IA-2A, and/or ZnT8A) that stay positive
- If you are pregnant or breastfeeding (or recently postpartum), you cannot join
- You should not use medicines that affect the immune system or blood sugar (like steroids or diabetes pills)
- You should not have had major stomach surgery for weight loss (like gastric bypass/banding) or pancreas surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people with type 1 diabetes are treated and how their metabolism is doing. It will help doctors understand the condition better and improve care.
This study looks at how the body makes glucagon (a hormone that raises blood sugar) in children and teens with new type 1 diabetes. It aims to understand why some people may have dangerous low blood sugars, so doctors can better prevent them in the future.
This study uses a continuous glucose monitor (CGM) and an oral glucose tolerance test (OGTT) to check how well your body controls blood sugar. It is for people who may have early signs of diabetes or are at risk and want to better understand their glucose health.
This study uses a wearable sensor (like a smartwatch) to track your body's signals when blood sugar drops low. The goal is to understand low blood sugar patterns better, which may help improve prevention and treatment.
This trial tests a new continuous glucose monitor (CGM) designed to help manage blood sugar levels. You will wear the device for 15 days and attend three clinic visits to see how well it works.
This study tests a new continuous glucose monitor that checks your blood sugar levels in real time. It aims to see how accurate and safe it is for people with diabetes.
Hear when a new Type1 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.